| Name | Title | Contact Details |
|---|---|---|
Greg Strickland |
CEO | Profile |
demandDrive is the industry leader in sales development and demand generation. We provide clients with a full-service sales development function as well as data & demand generation programs to help them optimize their sales & marketing processes and increase revenue growth. demandDrive provides a dedicated team of Sales Development Reps and combines best practices in sales development and demand generation with industry-leading sales enablement tools to uncover and qualify new sales opportunities. demandDrive has become a pioneer in lead Generation, specializing in developing and executing custom sales / marketing programs for clients in the technology space. Services include, but are not limited to: - Integrated Inbound & Outbound Lead Generation - Startup Sales Acceleration - Data Services - Sales & Marketing Intelligence - Demand Generation Consulting demandDrive utilizes a consultative approach to kick-start lead generation and combines the flexibility of outsourcing with the expertise and continued development of a close-knit internal team. Dedicated Sales Development Reps are seasoned through an intensive dD Certification Program and work closely with clients sales and marketing teams to understand their product. This attention to detail allows for high volume, high quality and actionable sales opportunities. demandDrive has collected top honors such as being named to the Inc. 5000 list of fastest growing private companies in the US and being deemed one of the top 20 companies in the country for work-life balance (per Glassdoor).
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
For 25+ years, MIRACORP has served government and commercial clients. SMALL BUSINESS DESIGNATIONS -100% Woman-owned (WOSB) GSA Schedules: MAS - 47QSHA20D000Z NAICS CODE SERIES 541 - Professional, Scientific, Technical and Administrative Services 561 - Administrative and Facilities Support 611 - Educational Services
Bostons Grammy-winning Handel and Haydn Society performs Baroque and Classical music with a freshness, a vitality, and a creativity that inspires all ages. H+H has been captivating audiences for over 200 consecutive seasons (the most of any performing arts organization in the United States), speaking to its singular success at converting new audiences to this extraordinary music, generation after generation.
Miller Engineerings design and consulting team provides over 100 cumulative years of construction and design experience, which will ensure the success of your project.